You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 11, 2025

Drug Price Trends for URO-MP CAPSULE


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for URO-MP CAPSULE

Average Pharmacy Cost for URO-MP CAPSULE

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
URO-MP CAPSULE 58657-0456-01 1.57685 EACH 2025-01-22
URO-MP CAPSULE 58657-0456-01 1.61287 EACH 2024-12-18
URO-MP CAPSULE 58657-0456-01 1.54645 EACH 2024-11-20
URO-MP CAPSULE 58657-0456-01 1.70571 EACH 2024-10-23
URO-MP CAPSULE 58657-0456-01 1.65816 EACH 2024-09-18
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for URO-MP Capsule

Overview of URO-MP

URO-MP is a multi-ingredient medication belonging to the urinary antispasmodics drug class. It contains hyoscyamine, methenamine, methylene blue, phenyl salicylate, and sodium biphosphate, and is commonly used to manage symptoms associated with urinary tract infections (UTIs) and other urinary discomforts[1][4].

Market Position and Competitors

Market Share and Prescription Rates

URO-MP is one of the widely prescribed medications for UTI symptom relief. In 2020, it was estimated to have been prescribed to approximately 1.2 million people in the US, accounting for about 7% of prescriptions for UTI symptom relief medications. However, it trails behind other medications like Uribel, which was prescribed to around 2 million people in the same period, accounting for about 14% of such prescriptions[4].

Competing Medications

URO-MP competes with other medications such as Nitrofurantoin and Ciprofloxacin, which are also used to treat UTIs. These medications have different active ingredients and varying efficacy and safety profiles. For instance, Nitrofurantoin and Ciprofloxacin are antibiotics, whereas URO-MP is a combination of antispasmodic, analgesic, and urinary alkalizer components[2].

Pricing and Cost Analysis

Current Pricing

The cost of URO-MP capsules can vary depending on the pharmacy and the quantity purchased. For a supply of 100 capsules, the cost is approximately $92.23, which works out to about $0.92 per capsule. This pricing is for cash-paying customers and does not include insurance plans. Generic versions of URO-MP can be significantly cheaper, starting at around $0.82 per capsule for a 30-capsule supply[1][5].

Cost Comparison with Alternatives

When compared to Uribel, another commonly used medication for UTI symptoms, URO-MP can be more expensive on a per-day basis for brand-name versions. For example, 30 capsules of URO-MP can cost around $159, or about $5.30 per day, while 60 tablets of Uribel can cost approximately $273, or about $4.55 per day. However, generic versions of URO-MP can be more cost-effective[4].

Patient Assistance and Discount Programs

Discount Cards and Coupons

Patients can use discount cards and coupons to reduce the cost of URO-MP. For instance, the Drugs.com Discount Card can save up to 80% or more off the cost of prescription medicines, including URO-MP. However, there are no manufacturer promotions or patient assistance programs specifically for URO-MP[1].

Market Trends and Projections

Global Market Context

The global market for urinary tract infection treatments is part of a broader market that includes overactive bladder (OAB) treatments. The OAB market is expected to experience moderate growth, reaching $2.8 billion by 2030, with a compound annual growth rate (CAGR) of 2.7%. However, the early-to-mid forecast period (2020-2025) may see a decline in market value due to patent expiries of key products[3].

Specific Projections for URO-MP

Given the generic nature of URO-MP and the presence of competing medications, the pricing and market share of URO-MP are likely to remain stable or slightly decline. The launch of new pipeline products in the OAB and UTI treatment markets could impact the market share of existing medications like URO-MP. However, its established position and efficacy in managing UTI symptoms suggest it will continue to be a viable option for patients[3][4].

Side Effects and Efficacy

Efficacy

URO-MP has been shown to be effective in alleviating symptoms of UTIs from the beginning of treatment. It has a favorable side effect profile compared to many other UTI treatments and is widely prescribed due to its effectiveness and tolerability, even in elderly populations[4].

Side Effects

Common side effects of URO-MP include nausea, vomiting, dry mouth, dizziness or light-headedness, headaches, blurry vision, confusion, nervousness, restlessness, and heat sensitivity. Severe side effects can include acute glaucoma and serotonin syndrome[4].

Clinical Trials and Pipeline Analysis

Current Treatment Landscape

The current treatment landscape for UTIs and OAB includes a range of medications, with orally administered antimuscarinics and beta-3 adrenergic receptor agonists being common first-line treatments. URO-MP, with its combination of active ingredients, fits into this landscape as a multi-symptom relief medication[3].

Future Developments

The pipeline for UTI and OAB treatments includes novel molecular targets and mechanisms of action, such as gene therapy and P2RX3 antagonists. These developments could potentially impact the market share of existing medications like URO-MP, but its established efficacy and safety profile make it likely to remain a relevant treatment option[3].

Conclusion

URO-MP is a widely used medication for managing UTI symptoms, with a well-established market presence. While its pricing can be competitive, especially when considering generic versions, the medication's efficacy and tolerability ensure its continued relevance in the market.

Key Takeaways

  • Pricing: URO-MP capsules cost around $92 for a 100-capsule supply, with generic versions available at lower prices.
  • Market Share: URO-MP accounts for about 7% of UTI symptom relief prescriptions in the US.
  • Efficacy: URO-MP is effective in alleviating UTI symptoms with a favorable side effect profile.
  • Competitors: URO-MP competes with medications like Nitrofurantoin and Ciprofloxacin.
  • Market Trends: The market for UTI treatments is part of a broader OAB market expected to grow moderately by 2030.

FAQs

Q: What is URO-MP used for?

URO-MP is used to manage symptoms associated with urinary tract infections (UTIs) and other urinary discomforts.

Q: How much does URO-MP cost?

The cost of URO-MP can vary, but for a supply of 100 capsules, it is approximately $92.23, or about $0.92 per capsule.

Q: Are there any discount programs available for URO-MP?

Yes, patients can use discount cards like the Drugs.com Discount Card to save up to 80% or more off the cost of URO-MP.

Q: What are the common side effects of URO-MP?

Common side effects include nausea, vomiting, dry mouth, dizziness or light-headedness, headaches, and blurry vision.

Q: How does URO-MP compare to other UTI medications?

URO-MP is a multi-ingredient medication that competes with antibiotics like Nitrofurantoin and Ciprofloxacin, and other combination medications like Uribel.

Sources

  1. Drugs.com: Uro-MP Prices, Coupons, Copay Cards & Patient Assistance.
  2. Drugs.com: Uro-MP Alternatives Compared.
  3. BusinessWire: Global Overactive Bladder Drug Forecast and Market Analysis Report 2021-2030.
  4. WithPower: Uro Mp vs Uribel.
  5. PharmacyChecker: Uro-Mp Prices - U.S. & International.

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.